TITLE

Inhaled micronised gentamicin powder: a new delivery system

AUTHOR(S)
Goldman, J M; Bayston, S M; O'Connor, S; Meigh, R E
PUB. DATE
December 1990
SOURCE
Thorax;Dec1990, Vol. 45 Issue 12, p939
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66101481

 

Related Articles

  • Dry powder inhaler.  // Pharmaceutical Technology Europe;Apr2010, Vol. 22 Issue 4, p58 

    The article evaluates the Taper Dry Powder Inhaler from 3M Drug Delivery Systems.

  • Dry Powder Inhaler Stores APIs on Carrier Tape.  // Pharmaceutical Processing;Aug2011, Vol. 26 Issue 7, p17 

    The article mentions the Taper Dry Powder Inhaler from the company 3M Drug Delivery System.

  • Dry Powder Inhaler Stores APIs on a Microstructured Carrier Tape.  // Pharmaceutical Processing;Mar2011, Vol. 26 Issue 2, p42 

    The article offers brief information on the Taper Dry Powder Inhaler from 3M Drug Delivery Systems.

  • Emerging Research Opportunities on Oral Inhalation Technology. Rios, Maribel // Pharmaceutical Technology;Jul2003, Vol. 27 Issue 7, p42 

    Reports on advances in formulations and inhalation systems for pulmonary delivery. Oral respiratory drug delivery systems; Inhalable insulin; Molecular and particle engineering; Pressurized metered-dose inhalers; Nebulizers; Liquid-based inhalers; Dry-powder delivery; Particle-size distribution...

  • First CFC-free, dry-powder corticosteroid inhaler for asthma.  // Modern Medicine;Sep97, Vol. 65 Issue 9, p42 

    Reports that a chlorofluorocarbon-free delivery system for the drug budesonide inhalation powder from Astra has been cleared for the maintenance treatment of asthma. Indications; Feature.

  • Developments in inhaleable drug delivery.  // Life Science Today;Apr2001, Vol. 2 Issue 2, p28 

    Reports on developments in pulmonary drug delivery that help overcome obstacles associated with injection for respiratory diseases. Limitations of macromolecule delivery systems; Use of compressed air to aerolize powder particles by Inhale Therapeutic Systems Inc.

  • Drug-delivery solutions.  // Pharmaceutical Technology;Apr2012, Vol. 36 Issue 4, p151 

    The article offers information on 3M Drug Delivery Systems which provides inhalation and transdermal drug-delivery systems and components, including dry-powder inhaler and microneedle technologies, plus contract manufacturing services for technical success.

  • Investigation into the Influence of Primary Crystallization Conditions on the Mechanical Properties and Secondary Processing Behaviour of Fluticasone Propionate for Carrier Based Dry Powder Inhaler Formulations. Kubavat, Harshal; Shur, Jagdeep; Ruecroft, Graham; Hipkiss, David; Price, Robert // Pharmaceutical Research;Apr2012, Vol. 29 Issue 4, p994 

    Purpose: To investigate the influence of primary crystallization conditions on the mechanical properties and secondary processing behaviour of fluticasone propionate (FP) for carrier based dry powder inhaler (DPI) formulations. Methods: Young's modulus of FP crystals produced using different...

  • DPI agreement.  // Pharmaceutical Technology Europe;Dec2004, Vol. 16 Issue 12, p10 

    This article reports that in a codevelopment and joint marketing agreement, MicroDose Technologies Inc.'s dry powder inhaler technology will be combined with 3M Drug Delivery Systems' global inhalation product development, formulation development and manufacturing capabilities. The partnership...

  • Fit for the Lung? Faulkes, Jon; Mickley, Emma J. // Pharmaceutical Technology Europe;Sep2014, Vol. 26 Issue 9, p38 

    The article discusses the benefits of engineered particle approach for inhaled drug delivery and treatment of various diseases including diabetes, asthma and cancer. Topics include the issues of micronisation, the opportunities of inhaled drugs in the pharmaceutical industry and the development...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics